Overview

TXA in Spinal Fusion

Status:
Recruiting

Trial end date:
2022-08-01

Target enrollment:

Participant gender:

Summary

Tranexamic acid and placebo will be given during surgery to patients who have elected to undergo lumber interbody fusion on 2 or more levels. Information regarding blood loss, transfusions needed, and duration of hospital stay will be collected.

Phase:

Phase 2

Details

Lead Sponsor:

Mario Zanaty

Treatments:

Tranexamic Acid